Lantern Pharma Inc..
LTRN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Lantern Pharma Inc. is a clinical-stage biopharmaceutical company focused on leveraging artificial intelligence (AI) and machine learning (ML) to accelerate the development of targeted and personalized cancer therapies. The company utilizes its proprietary AI platform, RADR®, to identify and validat...Show More
Better Health for All
20
Lantern Pharma is a clinical-stage biopharmaceutical company focused on developing cancer therapies, with its entire business devoted to health improvement. The company is conducting clinical trials for drug candidates such as LP-300, LP-184, and LP-284, targeting conditions like lung cancer in never-smokers, glioblastoma, and triple-negative breast cancer.
1
Preliminary safety data from a lead-in cohort for LP-300 showed an 86% clinical benefit rate and a 43% objective response rate.
2
The company has an Expanded Access Policy for investigational drug LP-184, which acknowledges requests within 3 business days and complies with local laws and regulations.
3
Fair Money & Economic Opportunity
0
No evidence available to assess Lantern Pharma Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantitative data was found across the provided articles for Lantern Pharma Inc. regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.
1
Therefore, no assessment can be made against these KPIs.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Lantern Pharma Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-50
Lantern Pharma Inc. has a formal Whistleblower Policy (POL-0036 Rev C), revised November 11, 2022.
1
This policy includes reporting options via senior executives, the Board, or a hotline, provides hotline numbers (US and International), and outlines procedures for anonymous reporting, protection against retaliation, and investigations.
2
However, there is no explicit evidence of independent investigation processes, nor details on training, uptake, or resolution times. An anti-corruption and anti-bribery policy is referenced as part of the company's Code of Conduct, but no specific details regarding its strength, enforcement, or scope are provided.
3
Kind to Animals
0
The company uses animal testing in its research collaborations, as evidenced by both articles.
1
specifically mentions the use of "animal models" alongside "laboratory models" and other techniques.
2
However, the provided articles do not offer any specific, quantifiable data regarding the volume of animals used, the company's animal testing policy, the extent of non-animal testing methods employed, or any investment in animal-free alternatives. Therefore, no KPIs can be scored against the rubric's quantitative thresholds.
No War, No Weapons
0
Lantern Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies using its AI platform, RADR®.
1
All described activities, including clinical trials for LP-184 and LP-284, are explicitly for oncology treatment.
2
There is no evidence of the company having any revenue from arms or defense contracts, or any involvement in military or conflict-related activities.
3
The company's AI platform is consistently described as being used for oncology-specific data analysis and drug development, with no indication of military applications or dual-use R&D investment in military technology.
4
The company's entire R&D spending is dedicated to developing cancer therapies, which aligns with a 100:0 ratio for peace and humanitarian technology investment.
Planet-Friendly Business
0
No specific, concrete data points for Lantern Pharma Inc. were found across any of the provided articles for the Planet-Friendly Business KPIs. The articles explicitly state that sustainability data, including environmental, social, and governance (ESG) metrics such as emissions, water use, waste diversion, and biodiversity efforts, is not available for the company.
1
Respect for Cultures & Communities
0
No evidence available to assess Lantern Pharma Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No specific, concrete data points were found across the provided articles to assess Lantern Pharma Inc. against any of the 'Safe & Smart Tech' KPIs. The articles either explicitly state that information is not applicable or not mentioned for relevant metrics, or provide details that are too general to map to the quantitative thresholds of the rubric. For instance, while a privacy policy is mentioned, it lacks specific details on data breach severity, AI ethics governance, cybersecurity investment, privacy certifications, encryption implementation, AI audit practices, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty effectiveness, privacy by design, security testing coverage, data minimization, regulatory compliance, algorithmic harm remediation, or digital rights advocacy.
1
Zero Waste & Sustainable Products
0
No specific, concrete evidence regarding Lantern Pharma Inc.'s performance or initiatives related to 'Zero Waste & Sustainable Products' was found in the provided articles. The articles either discuss general industry practices, regulatory trends, or other companies, or explicitly state that no relevant information for LTRN.US is available.
1